Roth Capital's Joe Pantginis is one of the worst biotech analysts on the Street. i dont recall a single call this guy has gotten right. Roth is right up there with Rodman as one of the scumiest firms on the street.
Didnt Pantginis have a negative bias on Ariad, at Cannacord?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.